An analysis finds a “one size fits all” approach to prescribing opioids after surgery poses risks for addiction in certain patients.

After her 17-month-old daughter got a life-threatening case of COVID, Andrea Bell is encouraging others to continue protecting those that can’t get vaccinated. 

A research team from Michigan Medicine has developed a new potential treatment for fatty liver disease in patients with partial lipodystrophy and/or NASH.

When a father and his two kids developed an array of peculiar symptoms, doctors, Brazilian researchers and the NIH partnered to find a diagnosis and path to treatment.

Michigan Medicine is establishing clinics to provide post-discharge care to both adults and pediatric patients experiencing these long-term post COVID symptoms and complications.

Thanks to the donations from Ken and Kimberly Whipple and Ken and Jeanne Levy-Church, U-M Nursing partnered with Studio Elsewhere to install a Recharge Room: A place of calm in the middle of it all, in the Frankel Cardiovascular Center, Med Inn and C.S. Mott Children’s Hospital.

A phase 3 clinical trial finds an anti-inflammatory drug used in rheumatoid arthritis can preserve lung function in patients with systemic sclerosis.

Inhibiting IRE1α, a molecule activated by the endoplasmic reticulum in neutrophils, counters disease progression in lupus mice

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Research finds juvenile myositis and lupus share an inflammatory pathway, but their  pathophysiological differences may serve as diagnostic biomarkers in future studies.

Livonia resident Paul DeWyse reflects on being the hospital’s first patient, feeling like a social pariah and how precious life is.

A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities.

To help achieve immediate and substantial benefits for societies and people living with vision impairment, expert authors call on governments to include eye health in broader health care planning and financing, harness new technology to improve diagnosis and treatment, and expand the eye health workforce, so that everyone can access high-quality eye care.

A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.

Screening and Intervention for Glaucoma and Eye Health through Telemedicine (SIGHT) – Program allows Michigan Medicine doctors to virtually screen patients for glaucoma and other eye diseases that can eventually lead to vision loss.